Publications by authors named "Kurt Lustig"

Article Synopsis
  • - Argentine hemorrhagic fever, caused by the Junín virus (JUNV), has a high mortality rate and currently relies on limited treatments like immune plasma, highlighting the need for new antiviral therapies.
  • - The fusion inhibitor LHF-535 and nucleoside analog favipiravir have shown potential in combating arenaviral infections, but using favipiravir alone requires high doses for effectiveness against JUNV.
  • - Combining LHF-535 with a lower dose of favipiravir in guinea pig models resulted in complete protection from JUNV, demonstrating the potential of this drug combination to broaden treatment options and prevent drug resistance.
View Article and Find Full Text PDF

Background: Immune checkpoint therapies have led to significant breakthroughs in cancer patient treatment in recent years. However, their efficiency is variable, and resistance to immunotherapies is common. VISTA is an immune-suppressive checkpoint inhibitor of T cell response belonging to the B7 family and a promising novel therapeutic target.

View Article and Find Full Text PDF

LHF-535 is a small molecule antiviral currently in development for the treatment of Lassa fever, a zoonotic disease endemic in West Africa that generates significant morbidity and mortality. Current treatment options are inadequate, and there are no approved therapeutics or vaccines for Lassa fever. LHF-535 was evaluated in a lethal guinea pig model of Lassa pathogenesis, using once-daily administration of a fixed dose (50 mg/kg/day) initiating either 1 or 3 days after inoculation with a lethal dose of Lassa virus.

View Article and Find Full Text PDF

Chemokines play a key role in leukocyte recruitment during inflammation and are implicated in the pathogenesis of a number of autoimmune diseases. As such, inhibiting chemokine signaling has been of keen interest for the development of therapeutic agents. This endeavor, however, has been hampered due to complexities in the chemokine system.

View Article and Find Full Text PDF

We previously reported that administration of an adeno-associated virus 2 (AAV2) vector encoding a rat tumor necrosis factor (TNF) receptor-immunoglobulin Fc (TNFR:Fc) fusion gene to rats with streptococcal cell wall-induced arthritis resulted in suppression of joint inflammation and cartilage and bone destruction, as well as expression of joint proinflammatory cytokines. In this study, we used an alternate rat model of arthritis to compare the serum levels and duration of TNFR:Fc protein expression following intramuscular administration of pseudotyped AAV-TNFR:Fc vectors based on serotypes 1, 2, and 5. All three pseudotyped AAV-TNFR:Fc vectors led to sustained expression of serum TNFR:Fc protein for at least one year.

View Article and Find Full Text PDF

Thalamocortical connections are a neuroanatomical feature shared among vertebrates, although the extent and organization of these connections vary among species. From an evolutionary standpoint, reptiles represent early stages of the pattern of connectivity between the thalamus and cortex, and elucidation of these pathways may help to reveal the biological significance of these projections. The present tract tracing study was performed to examine the organization of thalamocortical projections in the pond turtle, Pseudemys scripta elegans.

View Article and Find Full Text PDF

This study evaluated and compared delivery of the tumor necrosis factor alpha receptor (TNFR)-immunoglobulin G1 (IgG1) Fc fusion (TNFR:Fc) gene to the lung by single and repeat administrations of multiple pseudotyped adeno-associated virus (AAV) vectors as a means for achieving systemic distribution of the soluble TNFR:Fc protein. A single endotracheal administration of AAV[2/5]cytomegalovirus (CMV)-TNFR:Fc vector (containing the AAV2 inverted terminal repeats and AAV5 capsid) to the rat lung resulted in long-term, high levels of serum TNFR:Fc protein that gradually declined over a period of 8 months. Endotracheal delivery of AAV[2/1]CMV-TNFR:Fc resulted in serum TNFR:Fc protein levels that were detectable for at least 4 months but were 10-fold lower than that of the AAV[2/5] vector.

View Article and Find Full Text PDF